COVID-19 pharmacy student perceptions: pharmacists' impact during the COVID-19 pandemic

Pharmacists around the world are playing an active role in educating the public about COVID-19. First-year pharmacy students taking a healthcare course at Temple University in Philadelphia were asked to write papers based on the nature of a pharmacist’s contributions during the pandemic. 90% of the essays outlined the importance of community pharmacists, as they are the most accessible healthcare professional, providing immediate social interaction and drug expertise. They help minimize the need for hospital visits, limiting their time in public, therefore reducing their risk of becoming infected. For the pharmacies that have a drive-thru window, over-the-counter medications and other necessities can be sold to decrease the likelihood of transmission. Many students also proposed the opportunity for more leniency in prescribing power. Unless pharmacists are within a collaborative practice agreement, they cannot prescribe even maintenance medication. Due to the pandemic, it has become increasingly hard to reach the doctor or see them in person, as most offices have switched to telehealth. Clinical pharmacists operating out of hospitals have the opportunity to oversee proposed treatment options or experimental drugs, such as remdesivir. Retail pharmacies are emerging as key resources in this pandemic, and it is important that students see this as a vibrant and important form of pharmacy practice.

COVID-19; Pandemic; Pharmacy; Pharmacists; Students; Industry; Community; Hospital

[1] Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information. International Journal of Clinical Pharmacy. 2020; 42: 1197–1206.

[2] Merks P, Jakubowska M, Drelich E, Świeczkowski D, Bogusz J, Bilmin K, et al. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic. Research in Social and Administrative Pharmacy. 2020; 17: 1807–1812.

[3] Erku DA, Belachew SA, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, et al. When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Research in Social and Administrative Pharmacy. 2021; 17: 1954–1963.

[4] Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic. Preventing Chronic Disease. 2020; 17: E69.

[5] Di Girolamo N, Meursinge Reynders R. Characteristics of scientific articles on COVID-19 published during the initial 3 months of the pandemic. Scientometrics. 2020; 125: 795–812.

[6] Elbeddini A, Prabaharan T, Almasalkhi S, Tran C. Pharmacists and COVID-19. Journal of Pharmaceutical Policy and Practice. 2020; 13: 36.

[7] Hayden JC, Parkin R. The challenges of COVID-19 for community phar-macists and opportunities for the future. Irish Journal of Psychological Medicine. 2020; 37: 198–203.

[8] Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Research in Social and Administrative Pharmacy. 2021; 17: 1897–1902.

[9] Johnston K, O’Reilly CL, Cooper G, Mitchell I. The burden of COVID-19 on pharmacists. Journal of the American Pharmacists Association. 2021; 61: e61–e64.

[10] Zheng S, Yang L, Zhou P, Li H, Liu F, Zhao R. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Research in Social and Administrative Pharmacy. 2021; 17: 1819–1824.

[11] Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy. 2021; 17: 1813–1818.

[12] Song Z, Hu Y, Zheng S, Yang L, Zhao R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recom-mendations and guidance from clinical experience. Research in Social and Administrative Pharmacy. 2021; 17: 2027–2031.

[13] Mallhi TH, Liaqat A, Abid A, Khan YH, Alotaibi NH, Alzarea AI, et al. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Frontiers in Public Health. 2020; 8: 561924.

[14] Baye AM, Ababu A, Bayisa R, Abdella M, Diriba E, Wale M, et al. Perspectives of compounding pharmacists on alcohol-based hand sanitizer production and utilization for COVID-19 prevention in Addis Ababa, Ethiopia: A descriptive phenomenology study. PLoS ONE. 2021; 16: e0250020.

[15] Bragazzi NL, Mansour M, Bonsignore A, Ciliberti R. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharmacy. 2020; 8: 140.